Episodes

  • The Big Three: When Your Brain, Skin, and Sleep All Go Rogue
    May 5 2026
    This episode explores three major menopausal symptoms—skin changes, cognitive issues, and sleep disruption—through recent research and expert interviews. Nykki examines how these symptoms are interconnected and discusses new approaches to treatment, from understanding skin as a dynamic immune system to developing targeted interventions for brain fog and addressing the sleep crisis in menopause. Key Takeaways: • Menopausal skin changes involve barrier function and immune system disruption, not just collagen loss, requiring different treatment approaches than younger skin • New research supports development of specific psychosocial interventions for menopausal cognitive symptoms, moving beyond generic "brain training" • Poor sleep during menopause increases risks for cardiovascular disease, depression, cognitive decline, and other health problems—it's not just about being tired • Sleep apnea becomes more common after menopause due to hormonal changes affecting upper airway stability • Skin, cognitive, and sleep symptoms are interconnected through hormonal and immune system changes Sources & References: • Rewriting the Rules of Skincare with Dr. Mimi V (https://notyourmothersmenopause.libsyn.com/ep-208-breakouts-wrinkles-and-the-barrier-rewriting-the-rules-of-skincare-with-dr-mimi-v) - Not Your Mother's Menopause • Mixed methods research for cognitive symptoms in menopause (https://pubmed.ncbi.nlm.nih.gov/42012840/?utm_source=HotFlasherBot&utm_medium=rss&utm_campaign=None&utm_content=9433353&fc=None&ff=20260505090356&v=2.19.0.post6+133c1fe) - Menopause (NAMS Journal) • The Sleep Crisis in Menopause with Dr. Andrea Matsumura (https://example.com) - unPAUSED with Dr. Mary Claire Haver Listen with full show notes: https://hotflasher.com/episodes/2026-05-05-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
    Show More Show Less
    8 mins
  • New Hot Flash Drug, Brain Fog Solutions, and Military Menopause Gaps
    May 4 2026
    New research highlights promising developments in menopause treatment and identifies important gaps. A novel hot flash medication shows good results in Chinese women, researchers are developing targeted interventions for brain fog, and the first systematic review of military menopause reveals significant knowledge gaps that could affect women in high-stress careers. Key Takeaways: • GS1-144, a new neurokinin 3 receptor antagonist, significantly reduced hot flash frequency and severity in Chinese women with good safety profile • Researchers are developing evidence-based psychosocial interventions specifically for cognitive symptoms during menopause transition, treating brain fog as a legitimate medical concern • The first systematic review of military menopause research revealed major knowledge gaps about how symptoms interact with combat roles, deployment, and extreme environments • Menopause research is becoming more targeted, addressing specific populations and circumstances rather than assuming one-size-fits-all approaches • Military menopause research could eventually benefit civilian women in other high-stress, high-performance careers Sources & References: • Novel neurokinin 3 receptor antagonist GS1-144 shows efficacy for hot flashes in Chinese women (https://pubmed.ncbi.nlm.nih.gov/41979542/?utm_source=HotFlasherBot&utm_medium=rss&utm_campaign=None&utm_content=9433353&fc=None&ff=20260504091703&v=2.19.0.post6+133c1fe) - PubMed • Research on developing evidence-based interventions for cognitive symptoms during menopause (https://pubmed.ncbi.nlm.nih.gov/42012840/?utm_source=HotFlasherBot&utm_medium=rss&utm_campaign=None&utm_content=9433353&fc=None&ff=20260504091703&v=2.19.0.post6+133c1fe) - PubMed • First systematic review reveals research gaps for menopause in military contexts (https://pubmed.ncbi.nlm.nih.gov/41945466/?utm_source=HotFlasherBot&utm_medium=rss&utm_campaign=None&utm_content=9433353&fc=None&ff=20260504091703&v=2.19.0.post6+133c1fe) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-05-04-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
    Show More Show Less
    7 mins
  • Delaying Menopause at 35, AI's Organ Age Discovery & Acne That Won't Quit
    May 1 2026
    This episode explores a 35-year-old woman's quest to delay menopause until 60 through experimental treatments, new AI research showing menopause affects different organs unequally, and dermatologist advice on treating menopause acne without making it worse. The discussion covers fertility preservation, personalized menopause treatment possibilities, and practical skincare adjustments for mature skin. Key Takeaways: • Experimental treatments like ovarian tissue preservation may help delay menopause, but long-term data is still limited • AI research reveals menopause causes different molecular aging patterns in different organs, potentially leading to more targeted treatments • Menopause acne differs from teenage acne and requires gentler treatment approaches to avoid skin irritation • Harsh acne treatments can worsen mature skin during menopause due to increased sensitivity • Hormonal changes during menopause create relative androgen dominance that can trigger adult acne Sources & References: • Menopause acne treatment mistakes and dermatologist recommendations (https://news.google.com/rss/articles/CBMihAFBVV95cUxOSl8tYzlkNTFxRE5xN3hZZTdlY3RrYVpYa2ltRVQwWjMzVHBSdEh3bFc4eUEtcWd1Y0otWlJLdHRwSUhnN2xJdnp2bVpTRDdmZVYwSE1CV2RaOVhLLTFQcURHaXg1Xy1vMG9Qd0RWR2VEY3lxRDR5RE14UkFsQWJNb1RvVVQ?oc=5) - NBC News • 35-year-old woman's journey to delay menopause until 60 (https://news.google.com/rss/articles/CBMikwFBVV95cUxNMVloTjR3aktMTXRfZjhzMmI1YkdWc2VjMklRVGlBQlVRWkVFMlgteV80OElXXzAteVJGaEF0bXJaN3J3eXVUbHdBU09CVDdHZnBDMWc3clk1Nk91cnpHQlNneDFLanJ3VmJDZmVrT2Q4QXhkSVFSWGhWZFZESGNnam1RZU1ZX2pITVF1c25lSmQxVlE?oc=5) - Business Insider • AI research reveals menopause affects organ aging differently (https://news.google.com/rss/articles/CBMif0FVX3lxTE42Zmcxb3JHYllkV0xobUZKNFFBY1M0eWRYUzRzaHhTV3oyeG53Tk04VkZqSHlqSmktZ1ZfUEpCamQtNFhOb254U01Bcks1Y0ZHT19UTkhNcUFCX3h2UlJxUU40TDl0QTNYY1pfTTlPNml6NWNDblUwWV9YWWtZaHc?oc=5) - Medical Xpress Listen with full show notes: https://hotflasher.com/episodes/2026-05-01-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
    Show More Show Less
    7 mins
  • AI Maps Menopause + Heart Risk + New Hot Flash Drug
    Apr 30 2026
    New AI research reveals that different organs age at different rates during menopause, with brain, heart, and bone tissue showing the most dramatic changes. A major JAMA study found women with premature menopause face 40% higher lifetime heart attack risk. Meanwhile, a promising new non-hormonal drug designed specifically for hot flashes shows significant results in clinical trials. Key Takeaways: • AI mapping shows brain, cardiovascular system, and bones experience the most dramatic molecular aging during menopause • Women experiencing menopause before age 40 have 40% higher lifetime risk of coronary heart disease • Premature menopause should be treated as an independent cardiovascular risk factor requiring proactive monitoring • New drug GS1-144 significantly reduced hot flash frequency and severity in clinical trials • Unlike current options, GS1-144 was specifically designed to target menopausal symptoms rather than being a repurposed medication Sources & References: • AI unveils molecular impact of menopause across female organs (https://news.google.com/rss/articles/CBMif0FVX3lxTE42Zmcxb3JHYllkV0xobUZKNFFBY1M0eWRYUzRzaHhTV3oyeG53Tk04VkZqSHlqSmktZ1ZfUEpCamQtNFhOb254U01Bcks1Y0ZHT19UTkhNcUFCX3h2UlJxUU40TDl0QTNYY1pfTTlPNml6NWNDblUwWV9YWWtZaHc?oc=5) - Medical Xpress • Premature menopause linked with 40% higher heart attack risk (https://jamanetwork.com/journals/jama/fullarticle/2847411) - JAMA Cardiology • New neurokinin 3 receptor antagonist shows promise for hot flashes (https://pubmed.ncbi.nlm.nih.gov/41979542/?utm_source=HotFlasherBot&utm_medium=rss&utm_campaign=None&utm_content=9433353&fc=None&ff=20260430091510&v=2.19.0.post6+133c1fe) - Menopause Journal Listen with full show notes: https://hotflasher.com/episodes/2026-04-30-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
    Show More Show Less
    8 mins
  • FDA Drops HRT Warning + Why TikTok's Pepcid "Cure" Is Dangerous
    Apr 29 2026
    The FDA removed its black box warning from hormone therapy after 20+ years, while doctors debunk a dangerous TikTok trend claiming antihistamines cure menopause. Plus, new AI research reveals menopause ages different body systems at different rates, challenging common assumptions about menopause and aging. Key Takeaways: • The FDA removed the black box warning from hormone therapy in November 2025, reflecting evolved understanding of HRT risks and benefits • TikTok's antihistamine/Pepcid menopause "cure" is dangerous misinformation that bypasses proper medical care • Long-term use of antihistamines like Benadryl has been linked to increased dementia risk in older adults • AI research shows menopause affects cardiovascular and reproductive systems more than immune and liver systems • Menopause doesn't uniformly accelerate aging but creates specific vulnerabilities in certain body systems Sources & References: • Doctor debunks viral menopause treatment trend involving antihistamines and Pepcid (https://news.google.com/rss/articles/CBMinwFBVV95cUxOdkllU0pVZ0hsbTJwRFdjT2JXejBQR2lPd29remhWcFdiSmhTX0lzdDdKOURUS25Hbzdsb3JwSmhDUnV2N1kxRHhhM1dobmJhM3owbXNPeks0NHBmQWxtVlQ2SDhSa0pwcjJzWTZBQkd6NmlqVk9hQTZBVDJLWGlha2JVOWVYR0JMdXlNMjVhcElBdXZVTmY0c295ZGI1UUnSAaQBQVVfeXFMTXZmTHhSYnFJUDQ3NFBuakJ6M1ZjTjVhSjAtYlVrdEtJSzcwQjhmSjBmSWtETEFUVmV1R1hQVjZIM0tucFF2dDRQdjJoTHlJTjdlUGw4ZWVUcGV0UVZGbko3YnRJOWI0WlhiZW5GRzdoVUl2cmJ5ZjNXcGVDQTZ2VzEzekF1bTFsWTQwVU9YRVoyUDZaY1l1b2Q4ZmxoRVoyempZUXI?oc=5) - Good Morning America • Menopause doesn't age the body evenly, AI study finds (https://news.google.com/rss/articles/CBMitwFBVV95cUxNVGpBLXFON2JPbFh1Zi1ZdW9UY2dJZkVLcUJDTGE2Y3Ftd1A4RUJqR00tcDlMcnpHcThWODhFQk44c184Z3lKMG9Qb1BCUjFBX2ZpX2g4ZGNabnhtcmFwWV93R21aZVVYclRWUlMtaGlxRzdTN1dKX21HaTYwZkxMaUFBR0hFcWJJNzFzcHNFLTF2N1Vib29hZjY5RUJNQ21ZWnYxdGdtcEpLaWxvUG56dVJjOXp5S2c?oc=5) - Euronews • The Food and Drug Administration boxed warning on menopausal hormone therapy: history, impact, and regulatory inflection point (https://pubmed.ncbi.nlm.nih.gov/41979564/?utm_source=HotFlasherBot&utm_medium=rss&utm_campaign=None&utm_content=9433353&fc=None&ff=20260429091622&v=2.19.0.post6+133c1fe) - NAMS Journal Listen with full show notes: https://hotflasher.com/episodes/2026-04-29-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
    Show More Show Less
    8 mins
  • The Symptoms That Don't Stop: Endometriosis, Oral Health, and Your Collagen
    Apr 28 2026
    This episode explores three lesser-known menopause symptoms: persistent endometriosis after periods stop, oral health changes including dry mouth and gum disease, and the so-called "collagen cliff" affecting skin and joints. Nykki examines recent research showing how these symptoms connect to hormonal changes and why they often get overlooked by healthcare providers. Key Takeaways: • Endometriosis symptoms can persist after menopause despite common assumptions that declining estrogen will resolve them • Postmenopausal women show significantly different oral health patterns, including increased dry mouth, gum disease, and taste changes • The "collagen cliff" concept has some scientific basis but may be overstated - collagen decline is gradual but becomes more noticeable around menopause • These symptoms are interconnected parts of hormonal changes rather than separate age-related issues • Healthcare providers need better awareness of whole-body menopause symptoms beyond reproductive health Sources & References: • Endometriosis beyond menopause: a call for greater clinical awareness (https://pubmed.ncbi.nlm.nih.gov/42047158/) - PubMed • Assessment of Oral and Emotional Health in Pre-Menopausal and Post-Menopausal Women: A Cross-Sectional Study (https://pubmed.ncbi.nlm.nih.gov/42045089/) - PubMed • Does menopause cause a 'collagen cliff'? What you need to know (https://news.google.com/rss/articles/CBMimgFBVV95cUxNM01pZGs4N1M0NktDSlZCNXk0SEtmNGV2OWp5OXg5RVhaTjFYY0swM3dTdHBqLW1yYkY3cWRPREFaaWFiMjA2R2NIWEk0R2h0eGxpb3JVZDltcWlMZ0ZLQU1MeDZTQ2VDYUFvNjlQMTQ0ZUNKcjh1U3RybHdqai12QmU0MkFHTXVPRC1pa0xkd3gyWkhiQnd4YlBB?oc=5) - The Conversation Listen with full show notes: https://hotflasher.com/episodes/2026-04-28-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
    Show More Show Less
    7 mins
  • Hair Loss, Hot Flash Breakthroughs, and the ADHD Connection
    Apr 27 2026
    A systematic review shows estrogen therapy may help with menopausal hair loss. A new non-hormonal drug GS1-144 targets hot flash mechanisms directly. And experts are exploring why ADHD diagnoses are rising in menopausal women as estrogen decline affects dopamine and focus. Key Takeaways: • Estrogen therapy shows promise for menopausal hair loss, but results vary and early treatment seems to work better • GS1-144, a neurokinin 3 receptor antagonist, significantly reduced hot flash frequency and severity in a phase 2 trial • More women in their 40s and 50s are being diagnosed with ADHD for the first time, possibly linked to declining estrogen affecting dopamine • Focus and attention issues that persist despite menopause treatment may warrant an ADHD evaluation Sources & References: • Menopause and hair loss in women: Exploring the hormonal transition (https://pubmed.ncbi.nlm.nih.gov/40318238/) - PubMed • Neurokinin 3 receptor antagonism for menopausal hot flashes (https://pubmed.ncbi.nlm.nih.gov/37541194/) - PubMed • ADHD Diagnoses May Be Rising In Menopausal Women (https://www.huffingtonpost.co.uk/entry/adhd-menopause-link-explained_uk_69ea1477e4b0bb584bc96158) - HuffPost Listen with full show notes: https://hotflasher.com/episodes/2026-04-27-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
    Show More Show Less
    9 mins
  • What Men Need to Know (Plus: Soy for Your Sex Life?)
    Apr 24 2026
    This episode explores what partners need to understand about menopause, reviews promising research on soy supplements for sexual function, and discusses surprising findings about how retirement can actually improve sexual desire. Key Takeaways: • Menopause education for partners should focus on the full scope of symptoms, not just hot flashes and mood changes • Soy isoflavone supplements (40-80mg daily) showed improvements in sexual function in multiple studies • Sexual desire actually improved for women during the retirement transition, suggesting work stress may impact libido more than aging • Phytoestrogens in soy may help support sexual health by mimicking some estrogen effects as natural levels decline • Retirement and major life transitions can create opportunities for sexual rediscovery in midlife and beyond Sources & References: • What Should Men Know About Menopause? (https://news.google.com/rss/articles/CBMijwFBVV95cUxQN3RWZDZWaTk4Nm5kd0tmLWhRMGJsUFBzeVJQeXBUXzI1OTdkSEFyYk95NXpEbEJaX3VyQU03WDVxZWJWcmZOMkdFRVEwVkc5aFJKV2paR3NlTWlJY01QWjF0bTVJTUtjSG1zRXdySHo1UzVfSEVIemYzQWo1NE5QXzY5aG1aamd2S1c3T1FBcw?oc=5) - The New York Times • Soy isoflavone supplementation and sexual function in postmenopausal women: systematic review (https://news.google.com/rss/articles/CBMiX0FVX3lxTE90SF9ZNEVRUzlKVEFaanowSVptMExVckJtSjlJbzNXOE5qUlIwY3FaUzZjVXZpbEkwR0xYN2FIeTFIOXlsOWxBa19qemNtUS1oSDdZMWV5MUJ0bE9JRnZJ?oc=5) - Nature • Changes in female sexual function during the retirement transition (https://pubmed.ncbi.nlm.nih.gov/41941322/?utm_source=HotFlasherBot&utm_medium=rss&utm_campaign=None&utm_content=9433353&fc=None&ff=20260424085259&v=2.19.0.post6+133c1fe) - Menopause Journal Listen with full show notes: https://hotflasher.com/episodes/2026-04-24-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.
    Show More Show Less
    7 mins